Ferozsons Laboratories (KAR:FEROZ) Cyclically Adjusted Book per Share: ₨204.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:FEROZ Ferozsons Laboratories Ltd KAR:FEROZ
75 GF Score
Price ₨384.68
GF Value ₨421.60
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Ferozsons Laboratories Cyclically Adjusted Book per Share?

Ferozsons Laboratories KAR:FEROZ -1.11% 75 Cyclically Adjusted Book per Share is ₨204.99 as of Mar. 2026. GuruFocus rates KAR:FEROZ with a GF Score™ of 75/100 and a GF Value™ of ₨421.60 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Ferozsons Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was ₨297.609. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₨204.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ferozsons Laboratories's average Cyclically Adjusted Book Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-22), Ferozsons Laboratories's current stock price is ₨384.68. Ferozsons Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₨204.99. Ferozsons Laboratories's Cyclically Adjusted PB Ratio of today is 1.88.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Ferozsons Laboratories was 2.28. The lowest was 0.91. And the median was 1.81.


Ferozsons Laboratories  (KAR:FEROZ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ferozsons Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=384.68/204.99
=1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Ferozsons Laboratories was 2.28. The lowest was 0.91. And the median was 1.81.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Ferozsons Laboratories Cyclically Adjusted Book per Share Related Terms


Ferozsons Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Ferozsons Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ferozsons Laboratories Cyclically Adjusted Book per Share Chart

Ferozsons Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 166.50 189.13

Ferozsons Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.17 189.13 194.35 197.62 204.99

KAR:FEROZ vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ferozsons Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's Cyclically Adjusted PB Ratio falls into.


KAR:FEROZ
75GF Score
Ferozsons Laboratories Ltd KAR:FEROZ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ferozsons Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ferozsons Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=297.609/330.2130*330.2130
=297.609

Current CPI (Mar. 2026) = 330.2130.

Ferozsons Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 128.060 241.018 175.452
201609 133.845 241.428 183.066
201612 129.105 241.432 176.580
201703 129.531 243.801 175.442
201706 126.811 244.955 170.948
201709 136.058 246.819 182.029
201712 125.518 246.524 168.128
201803 125.993 249.554 166.716
201806 124.644 251.989 163.337
201809 126.277 252.439 165.182
201812 125.726 251.233 165.250
201903 124.702 254.202 161.990
201906 125.826 256.143 162.212
201909 127.609 256.759 164.116
201912 126.613 256.974 162.698
202003 128.981 258.115 165.009
202006 147.704 257.797 189.195
202009 150.390 260.280 190.797
202012 155.647 260.474 197.320
202103 162.383 264.877 202.437
202106 171.921 271.696 208.949
202109 178.211 274.310 214.530
202112 176.622 278.802 209.191
202203 183.094 287.504 210.293
202206 178.697 296.311 199.142
202209 177.437 296.808 197.407
202212 180.073 296.797 200.347
202303 180.908 301.836 197.916
202306 182.155 305.109 197.142
202309 148.731 307.789 159.567
202312 190.552 306.746 205.130
202403 193.654 312.332 204.741
202406 258.306 314.175 271.492
202409 263.376 315.301 275.832
202412 275.370 315.605 288.116
202503 279.959 319.799 289.076
202506 284.690 322.561 291.444
202509 290.641 324.800 295.485
202512 292.830 324.054 298.396
202603 297.609 330.213 297.609

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₨204.99 mean?
Ferozsons Laboratories (KAR:FEROZ) has a Cyclically Adjusted Book per Share of ₨204.99 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ferozsons Laboratories and its competitors.
Is Ferozsons Laboratories' Cyclically Adjusted Book per Share too high?
Ferozsons Laboratories' current Cyclically Adjusted Book per Share is ₨204.99. Overall, Ferozsons Laboratories has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Ferozsons Laboratories' Cyclically Adjusted Book per Share of ₨204.99 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Ferozsons Laboratories and its competitors. Ferozsons Laboratories's current Cyclically Adjusted Book per Share is ₨204.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Fairly Valued. The stock's GF Value™ is ₨421.60, compared to a current price of ₨384.68 — trading 8.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₨204.99. Ferozsons Laboratories' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current Cyclically Adjusted Book per Share is ₨204.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued. The current stock price of ₨384.68 is trading 8.8% below its estimated GF Value™ of ₨421.60. GuruFocus considers Ferozsons Laboratories to be Fairly Valued.

Key valuation signals for KAR:FEROZ:

  • Cyclically Adjusted Book per Share: ₨204.99
  • GF Value™: ₨421.60 vs. price of ₨384.68 (8.8% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ferozsons Laboratories Business Description

Address 5 K.M Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
75GF Score

Get the complete analysis for KAR:FEROZ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨384.68
Price
₨421.60
GF Value